Review of the accumulated PLATO documentation supports reliable and consistent superiority of ticagrelor over clopidogrel in patients with acute coronary syndrome: Commentary on: DiNicolantonio JJ, Tomek A, Inactivations, deletions, non-adjudications, and downgrades of clinical endpoints on ticagrelor: serious concerns over the reliability of the PLATO trial, International Journal of Cardiology, 2013.

@article{Wallentin2014ReviewOT,
  title={Review of the accumulated PLATO documentation supports reliable and consistent superiority of ticagrelor over clopidogrel in patients with acute coronary syndrome: Commentary on: DiNicolantonio JJ, Tomek A, Inactivations, deletions, non-adjudications, and downgrades of clinical endpoints on ticagrelor: serious concerns over the reliability of the PLATO trial, International Journal of Cardiology, 2013.},
  author={Lars Wallentin and Richard C. Becker and Christopher Paul Cannon and Claes Held and Anders Himmelmann and Steen Elkj{\ae}r Husted and Stefan Karl James and Hugo S Katus and Kenneth W. Mahaffey and Karen S. Pieper and Robert F. Storey and Philippe Gabriel Steg and Robert A. Harrington},
  journal={International journal of cardiology},
  year={2014},
  volume={170 3},
  pages={e59-62}
}